Chidamide Combined With Benmelstobart, Nab-paclitaxel, and SBRT as Second-Line Treatment for Advanced BTC (clinicaltrials.gov) - Oct 23, 2026 - P2 | N=41 | Not yet recruiting | Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
New P2 trial • Biliary Cancer • Biliary Tract Cancer • Oncology • Solid Tumor
|